Kennedy, CDC
Digest more
Fiona Havers, who oversees CDC respiratory virus data, told colleagues she no longer had confidence the data would be used objectively to set vaccine policy.
3don MSN
Kennedy Jr. on Wednesday named eight new vaccine policy advisers to replace the panel that he abruptly dismissed earlier this week. They include a scientist who researched mRNA vaccine technology and became a conservative darling for his criticisms of COVID-19 vaccines,
5don MSN
The demonstration came a day after Health Secretary Robert F. Kennedy Jr. gutted a federal vaccine safety panel and vowed to replace all its members.
4don MSN
Just two days after retiring the entirety of the US Centers for Disease Control and Prevention’s vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government’s Covid-19 response to that committee.
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used to shape national vaccine policy has resigned, citing concerns over how such data would be used by the Trump administration.
The Advisory Committee on Immunization Practices helps the agency make recommendations on who should get certain vaccines.
Modern Engineering Marvels on MSN4d
Kennedy’s Overhaul of the CDC Vaccine Panel Raises Deep Questions About Science, Trust, and PolicyWe’ve taken a giant step backwards,” remarked Dr. Paul Offit, a leading vaccine scientist, after the abrupt dismissal of the entire CDC Advisory Committee on Immunization Practices (ACIP) by Health and Human Services Secretary Robert F.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday he promised to allow U.S. Senator Bill Cassidy to pick a candidate for a key panel of vaccine advisers. Kennedy, who has a long history of questioning the safety of vaccines contrary to scientific evidence,
Health and Human Services Secretary Robert F. Kennedy Jr.’s moves to upend decades of vaccine policy could hit patients hardest in their wallets, as shifting guidance over shots could make insurance coverage confusing and scattershot.